Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05793164
Other study ID # NFEC-2020-152
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date October 1, 2022

Study information

Verified date March 2023
Source Nanfang Hospital of Southern Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We retrospectively reviewed 1317 patients who had undergone HT and completed 9-month follow-up between January 2018 and June 2021 at 4 medical centers. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.


Description:

Postoperative folliculitis is a common complication after hair transplantation (HT) and requires effective preventive interventions. This study aimed to characterize postoperative folliculitis and determine the risk factors in patients underwent HT. The study was conducted at 4 clinical sites: Nanfang Hospital of Southern Medical University, the First Affiliated Hospital, Zhejiang University School of Medicine, the Affiliated Hospital of Guilin Medical University, and Peking University Third Hospital. Data of 1317 patients who had undergone HT and completed a 9-month follow-up from January 2018 to June 2021 were collected. The incidence of postoperative folliculitis and the patient demographics were assessed. Logistic regression analysis was used to identify the risk factors, and the characteristics of different types of folliculitis were compared.


Recruitment information / eligibility

Status Completed
Enrollment 1317
Est. completion date October 1, 2022
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - 1. Healthy adults between the ages of 18 ~ 60 2. patients suitable for autologous hair transplantation according to "the standard of hair transplantation" Exclusion Criteria: 1. Coagulation disorders, pregnancy and lactation, immunosuppression 2. With severe mental and psychological illness, impairment of body image 3. All kinds of immune-related alopecia in the progressive active stage 4. Patients judged by the investigator to be unsuitable for this study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention

Locations

Country Name City State
China Nanfang Hospital of Southern Medical University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Nanfang Hospital of Southern Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary folliculitis patients present folliculitis after hair transplantation 9 months after hair transplantation
See also
  Status Clinical Trial Phase
Completed NCT00746109 - Study of Wound Packing After Superficial Skin Abscess Drainage Phase 4
Completed NCT00352612 - Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections Phase 4
Completed NCT05345093 - Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis N/A
Completed NCT01094444 - Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis Phase 2
Completed NCT06052241 - Artificial Intelligence-based Prescription of Personalized Scalp Cosmetics N/A
Completed NCT00289588 - An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers N/A
Completed NCT01126268 - Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Phase 4
Suspended NCT01244256 - Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated Phase 2/Phase 3